Introduction
Fetal blood can enter the maternal circulation and a diagnosis of clinical fetomaternal hemorrhage (FMH) is made when fetal blood loss reaches a significant level leading to clinical symptoms due to fetal anemia, such as an abnormal fetal heart rate (FHR) patterns, decreased fetal movement, and/or fetal hydrops. FMH with clinical problems is estimated to occur in 1 of 3000-10,000 births [1] [2] [3] [4] , and affected infants may die, survive with disability, or exhibit normal development [1] [2] [3] [4] . FMH accounts for approximately 2.0% of Japanese infants with cerebral palsy caused by antenatal and/or intrapartum hypoxic conditions [5] .
Measurement of fetal middle cerebral artery peak systolic velocity (MCA-PSV) is a useful noninvasive test for detection of fetal anemia due to not only Rh alloimmunization [6] but also FMH [7] [8] [9] [10] [11] . However, as the MCA-PSV is measured in women with suspected fetal anemia and/or nonreassuring fetal status (NRFS), neither the time of significant FMH occurrence nor natural history of FMH is well understood. It is also unclear how long affected fetuses can tolerate clinical FMH. We recently encountered a case of FMH that was diagnosed immediately after birth, but was documented later to have lasted for at least 2 weeks prior to delivery.
Case Presentation
The Hokkaido University Hospital Institutional Review Board approved this study and the patient provided signed informed consent.
A 43-year-old nulliparous woman with body weight of 63 kg was admitted to our hospital at gestational week (GW) 31 À0/7 due to persistent nausea, proteinuria as evidenced by spot urine protein-to-creatinine ratio (mg/ mg) of 0. , and 59.5 cm/sec (1.63 MoM) at GW 28
. Nonspecific complaints of the mother were also recorded, including heartburn at GW 26 À6/7 , and heartburn and generalized itch without skin eruption at GW 28 À6/7 .
Investigations of FMH occurrence and diagnosis
Investigations were performed to determine the time of FMH occurrence. As the mother had participated in a prospective study unrelated to the present episode, two blood samples obtained at GW 28 À6/7 and at GW 31
were stocked and available for retrospective analyses. After receiving permission from the patient, flow cytometric assessment of FMH and determination of a-fetoprotein (AFP) were performed using these blood samples as well as blood obtained postpartum. This case already exhibited a high level of HbF fraction, 5.5% at GW 28 À6/7 (16 days prior to delivery) and 3.2% on the day of admission, and decreased levels of 0.6% on postpartum day 28 (Fig. 2) . The AFP level was already markedly elevated to 14,704 ng/mL (67 MoM according to the report of Ishijima [12] ) at GW 28 À6/7 , 23,000 ng/mL (82 MoM) on the day of admission, and 23,702 ng/mL (85 MoM) on postpartum day 0. At our hospital, ultrasound (including Doppler ultrasound) studies were performed after obtaining inclusive informed consent from all pregnant women at the beginning of pregnancy. Measurement of fetal MCA-PSV in otherwise healthy women used to be performed at the attending physician's discretion in our hospital. However, many physicians measured MCA-PSV in otherwise healthy women at our hospital; in a review of medical charts of 256 women who gave birth to singleton infants without clinical FMH at term (GW 37-40) in 2014 at our hospital, there were 100 women in whom fetal MCA-PSV was measured around GW 30 (between GW 28 À0/7 and GW 31
). The 100 measurements of MCA-PSV MoM performed by seven physicians were distributed normally (Fig. 3) , ranging from 0.60 to 1.95 MoM. The 25th, 50th, 75th, 90th, 95th, and 98th percentile MoM values were 0.85, 1.02, 1.12, 1.28, 1.44, and 1.52, respectively. The 95th percentile MoM of 1.44 was consistent with the results obtained in another study population without diagnosis of FMH by Kurmanavicius et al. [13] in which 95th percentile MCA-PSV of 56.1 cm/sec for GW 30 corresponded to 1.40 MoM according to Mari et al. [6] . Thus, the prevalence rate of MCA-PSV MoM ≥ 1.5 was estimated as approximately 1 in 50 fetuses without clinical FMH when tested around GW 30.
Discussion
Retrospective analysis of the maternal blood for HbF fraction and AFP concentration demonstrated unequivocally that this patient already suffered from FMH 16 days prior to delivery (at GW 28 À6/7 ). In addition, a consistent increase in fetal MCA-PSV, beginning with 1.46 MoM on GW 26
, suggested that this patient may have suffered from FMH for more than 3 weeks.
Fetal MCA-PSV measurement with Doppler ultrasound is noninvasive and useful for detection of fetal anemia, having a very high sensitivity of 100% with a cutoff of 1.5 MoM [6] . However, this test with a cutoff of 1.5 MoM has a low positive predictive value among the general population of pregnant women-an approxi- Our clinical path inevitably did not include measurement of fetal MCA-PSV for otherwise healthy women. Therefore, we did not have a predefined clinical path for cases that were incidentally found to have MCA-PSV MoM ≥ 1.5. The present review of 100 MCA-PSV measurements around GW 30 suggested that the prevalence rate of MCA-PSV MoM ≥ 1.5 was not high (approximately 2%). Therefore, the following treatments were recently introduced into our clinical path for cases with incidental MCA-PSV MoM ≥ 1.5: continuous FHR tracing for 30 min and determination of maternal AFP and HbF fraction levels. Clinical FMH is rare [1] [2] [3] [4] , with only a few FMH cases with in utero transfusion reported to date [7, 8, 14] . Cases with in utero transfusion were limited to those with hydrops fetalis [7, 8, 14] , and the effects of in utero transfusion on outcome have not yet been established. However, early suspicion of FMH, early confirmation of cord blood Hb concentration in pale neonates, and early blood transfusion may be effective for avoiding neurological sequelae in such anemic neonates [4] . The infant described here is being followed up carefully with respect to neurological development. , and 0.6% and 0.7% for rectangle areas in A and B, respectively, on PPD 28.
The mother complained of nonspecific symptoms, including heartburn at GW 26
, heartburn and generalized itch without skin eruption at GW 28 À6/7 , and persistent nausea on the day of admission. Rise of AST/ALT concomitant with a decreased platelet count on the day of admission suggested impending HELLP syndrome. It is unclear at present whether these symptoms were associated with the occurrence of FMH and whether the impending HELLP syndrome was associated with FMH, although a case with onset of HELLP syndrome soon after massive FMH caused by blunt abdominal trauma was reported previously [15] .
In conclusion, this case indicated the existence of persistent FMH. However, a policy of screening with MCA-PSV for detection of occult FMH targeting the general pregnant population was considered to be too labor intensive and not cost effective. 
